title: Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C.
authors.forename: Naoki
authors.initials: N
authors.lastname: Tanaka
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Ishida
authors.forename: Eiji
authors.initials: E
authors.lastname: Tanaka
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced*; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin